A pager looks quaint until someone urgently needs you. Spok has built a hospital communications business around that awkward fact - and learned an expensive lesson about chasing the next new thing.
A retirement administrator had more than 500 document templates. O’Neil helped reduce them to 15. Behind that small act of subtraction sits a business built to make complicated messages arrive intact.

He started in advertising as a teenager, built Evoke from digital-first roots, and spent two decades turning specialist pieces into one global healthcare agency. The revealing part is not the scale. It is his insistence that the work stays human.
M Booth Health spent years proving that specialist knowledge and consumer creativity could share an office. Then 2025 took away two large pieces of revenue - and the agency discovered that its sharpest growth tool was refusing most of the work offered to it.
For forty years, MCS Health has sold a peculiar advantage: the attention of a specialist shop with the reach of a network. Its 2025 reset shows what happens when a boutique decides scale should be borrowed, not owned.
Snow Companies built a healthcare agency around a stubborn idea: a patient story is not raw material to be extracted, polished and forgotten. It is a relationship - and, in regulated medicine, the relationship is the product.
JPA Health began with an unfashionable idea: healthcare messages work better when the people who understand policy, patients, science and data sit at the same table. Then it spent two years buying the chairs it was missing.
Lucid Group built a business around an awkward truth in medicine: approval is only the beginning. Its job is to move evidence through the far messier machinery of belief, behaviour and clinical practice.
rbb Communications built a national agency around a disarmingly practical idea: attention matters only when it changes behavior. Its case files reveal how research, media, creative work and measurement become one operating system.
Real Chemistry began as one consultant with a healthcare Rolodex. A bruising 2008 taught it a stranger lesson: when clients need several kinds of expertise at once, the agency itself has to become a portfolio.
The cleverest thing this communications firm ever communicated may have been its own identity: buy a niche cleantech agency, fold in digital and brand shops, then take the niche agency's name.
Ruder Finn began in a hotel linen closet. Seventy-eight years later, the independent PR firm is betting that the next communications advantage will come from turning scattered AI experiments into everyday agency work.
A London healthcare agency found its edge in a difficult combination: knowing the compliance rules cold, then making the work feel nothing like compliance. Its best proof is a Rick Astley joke that moved people to book hearing tests.
In 1983, Melissa Waggener Zorkin made a bet that technology would need translators. Four decades, several names and one stubbornly enduring Microsoft relationship later, her independent agency is still turning complicated change into stories people can use.
When live events vanished, the British agency discovered that a meeting is not a format. It is a behavior-change problem - and that distinction turned a near-shutdown into a wider communications business.
REALITYRx has spent 17 years testing a contrarian idea: in healthcare advertising, the useful unit of scale may not be headcount. It may be how quickly a senior person answers the phone.
From six-minute telexes to a healthcare brief spanning agency networks, the Brazilian-born executive has spent four decades making distance less important - without pretending difference does not exist.

After more than 25 years inside large healthcare agencies, Eric Muller has chosen an independent company for his next build. His brief at Lucid Group is to make science, strategy, creativity and technology move as one.
Inprela built a communications agency around an unfashionable bet: the most technical companies do not need louder marketing. They need someone who can find the human argument inside the machinery - and prove that it moved the business.
HDMZ spent decades learning how to explain difficult science. Its more interesting trick is deciding what should be explained at all - by starting at the desired business outcome and plotting backward.
For more than three decades, Caren Kagan Evans built campaigns around subjects that resist simplification - specialty pharmacy, counterfeit medicines, diabetes care and environmental regulation. ECI's trick was to make the technical travel.
120/80 GROUP started by choosing a niche most agencies treated as a side room. Then digital health swallowed the building - and the firm reorganized around what came next.
The Hershey consultancy does not sell attention for its own sake. It builds coalitions around the people whose trust a health company cannot manufacture - and measures what happens next.
A drug can be clinically precise and publicly unintelligible. KKH Advisors built a business in that gap - translating consequential science for the investors, reporters, partners and patients who decide what happens next.
Suzanne Lane began with little PR experience and one useful conviction: ordinary products become interesting when people understand why they matter. A women’s razor proved the point - and became a client relationship that lasted 21 years.
RH Strategic built a communications firm for ideas that are difficult to explain and expensive to misunderstand. Its wager is that influence can be engineered - and measured - without reducing public relations to a pile of clips.
Living in the Light has spent more than a decade making rare-disease stories less clinical and more human. Its method begins with a small but radical edit: move the diagnosis out of the center of the frame.
The boutique agency built a business around a hard editorial problem: making consequential science clear without making it careless.
RooneyPartners built a business around a useful contradiction: stay boutique, but arrive when the stakes are enormous. Its best work turns complicated moments - IPOs, clinical science, turnarounds and crises - into stories people can actually repeat.
LEVITATE built a business around a stubborn problem in medtech: the invention can be precise, the language cannot. Its answer is to make communications begin with the business goal - and the audience - rather than the press release.